Seelos Therapeutics, Inc. Common Stock
SEEL
SEEL was delisted on the 15th of October, 2024.
2 hedge funds and large institutions have $7.07M invested in Seelos Therapeutics, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and closing their positions.
1,275% more call options, than puts
Call options by funds: $55K | Put options by funds: $4K
0% more funds holding
Funds holding: 2 → 2 (0)
31% less capital invested
Capital invested by funds: $10.2M → $7.07M (-$3.13M)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$32K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$19K |
| 3 |
LPL Financial
San Diego,
California
|
-$12K |
| 4 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
-$6K |
| 5 |
AIG
American International Group
New York
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AG
26
Advisor Group
Phoenix,
Arizona
| $2K | – | – | – |
|
27
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $2K | – | – | – |
|
28
BlackRock
New York
| $1K | – | – | – |
|
|
ST
29
Sphinx Trading
Chicago,
Illinois
| $1K | – | – | – |
|
30
UBS Group
Zurich,
Switzerland
| $1K | – | – | – |
|
|
AIG
31
American International Group
New York
| – | -$3K | – | – |
|
|
BIM
32
BlackRock Investment Management
Wilmington,
Delaware
| – | -$6K | – | – |
|
33
Citigroup
New York
| – | -$1K | – | – |
|
|
34
Hudson Bay Capital Management
Stamford,
Connecticut
| – | -$32K | – | – |
|
|
35
LPL Financial
San Diego,
California
| – | -$12K | – | – |
|
|
TSS
36
Two Sigma Securities
New York
| – | -$19K | – | – |
|
SEEL Hedge Fund Activity: Q2 2016 in Review
2 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Seelos Therapeutics, Inc. Common Stock (SEEL) for Q2 2016, worth a combined $7.07M — down 31% from $10.2M a quarter earlier.
Fund positioning in SEEL was balanced in Q2 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
The largest seller was Hudson Bay Capital Management, cutting an estimated $32K.
- 2 institutional investors held Seelos Therapeutics, Inc. Common Stock (SEEL) as of Q2 2016, unchanged from Q1 2016.
- Funds reported $7.07M of Seelos Therapeutics, Inc. Common Stock stock for Q2 2016, down 31% quarter-over-quarter.
- 0 funds opened new Seelos Therapeutics, Inc. Common Stock positions in Q2 2016 and 0 closed out.
- The largest Seelos Therapeutics, Inc. Common Stock seller in Q2 2016 was Hudson Bay Capital Management, an estimated $32K sold.
Based on aggregated 13F filings for Q2 2016.